stars 1 stars 2 stars 3

AUMED, established in 2007, specializes in the research and development of innovative immunobiological preparations and pharmaceuticals. Initially focused on other industries, the company shifted to healthcare and pharmaceuticals in response to market demands. Today, AUMED drives pioneering research in advanced treatments, particularly in phage therapy. Its subsidiaries, AUMED Immunology a.s. and Aumed Pharma a.s., further enhance its impact in improving patient care and developing breakthrough therapies for conditions like acne and atopic eczema.

Aumed a.s. Questions

The Aumed a.s. annual revenue was $5.1 million in 2026.

Juraj Vronka is the CEO of Aumed a.s..

6 people are employed at Aumed a.s..

The NAICS codes for Aumed a.s. are [333, 33].

The SIC codes for Aumed a.s. are [352, 35].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users